* Champions Oncology Inc CSBR.OQ reported quarterly adjusted
earnings of 2 cents per share for the quarter ended in
October. The mean expectation of three analysts for the quarter
was for earnings of one cents per share.
* Revenue rose 16.5% to $11.79 million from a year ago;
analysts expected $11.55 million.
* Champions Oncology Inc's reported EPS for the quarter was 2
cents.
* The mean earnings estimate of analysts had fallen by
about 83.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Champions Oncology Inc shares had fallen by 20.2% this
quarter and lost 24.5% so far this year.
* The company reported quarterly net income of $277 thousand.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated December 13 at 10:01 p.m.
All figures in US dollars unless otherwise stated